We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA MULLS OPTIONS FOR INCREASING CLINICAL DATA SUBMISSIONS
FDA MULLS OPTIONS FOR INCREASING CLINICAL DATA SUBMISSIONS
June 16, 2004
The FDA is examining various strategies to increase compliance with a law mandating that companies engaged in clinical trials of drugs for serious or life-threatening diseases post notices about study data on a federal website.